AKYA - Akoya Biosciences, Inc.

1.29
-0.070   -5.426%

Share volume: 715,252
Last Updated: 07-07-2025
Measuring And Control Equipment/Lab Analytical Instruments: -0.11%

PREVIOUS CLOSE
CHG
CHG%
$1.36
-0.07
-0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
25%
Profitability 0%
Dept financing 21%
Liquidity 66%
Performance 40%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
-9.79%
2 Year
-72.49%
Key data
Stock price
$1.29
P/E Ratio 
0.00
DAY RANGE
$1.29 - $1.64
EPS 
-$0.96
52 WEEK RANGE
$0.93 - $1.64
52 WEEK CHANGE
-$7.19
MARKET CAP 
69.245 M
YIELD 
N/A
SHARES OUTSTANDING 
49.875 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
1.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Brian McKelligon
Region: US
Website: akoyabio.com
Employees: 90
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Akoya Biosciences provides spatial biology solutions focused on transforming discovery and clinical research. It offers single-cell resolution with spatial context that provides a wealth of information to visualize tissue organization and disease pathology on a molecular level. The company also provides PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition.

Recent news